Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biomedicine
Therapeutic DNA Vaccine Company Inovio Biomedical Reports 4th Quarter and Year-End 2007 Financial Results
April 2nd, 2008
Inovio Biomedical Corporation (AMEX:INO) ("Inovio") reported financial results for the quarter and year ended December 31, 2007. Total revenue for the quarter and year ended December 31, 2007, was $3.3 million and $4.8 million, respectively, compared with $1.5 million and $3.5 million for the same periods in 2006. Revenue consisted of license fees and milestone payments, and amounts earned from collaborative research and development arrangements and grants. Total operating expenses for the quarter and year ended December 31, 2007, was $5.1 million and $20.7 million, respectively, compared with $5.3 million and $16.8 million for the same periods in...
Source: Vaccine Weekly (2008-04-02)
|
